Stephens Investment Management Group LLC Halozyme Therapeutics, Inc. Transaction History
Stephens Investment Management Group LLC
- $7.08 Billion
- Q3 2024
A detailed history of Stephens Investment Management Group LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Stephens Investment Management Group LLC holds 1,359,730 shares of HALO stock, worth $64.6 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
1,359,730
Previous 1,421,904
4.37%
Holding current value
$64.6 Million
Previous $74.5 Million
4.49%
% of portfolio
1.1%
Previous 1.08%
Shares
18 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$838 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$613 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$315 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$193 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$162 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.62B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...